Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2025-12-24 @ 9:36 PM
NCT ID:
NCT02255032
Eligibility Criteria:
Inclusion Criteria:
* diagnosis of noninfectious uveitis
* diagnosis of macular edema associated with noninfectious uveitis
Exclusion Criteria:
* any ocular trauma within the immediate 6 months prior to treatment
* any photocoagulation or cryotherapy in the 6 months prior to treatment
* any IVT injection of anti-VEGF treatment in the 2 months prior to treatment
* any eye diseases other than uveitis and ME that could compromise central visual acuity
* any previous suprachoroidal injection of triamcinolone acetonide in the study eye
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02255032
Study Brief:
Protocol Section:
NCT02255032